Sleep Apnea News and Research

RSS

FDA approves ImThera Medical's investigational device exemption for pivotal study

ImThera Medical, Inc., a privately held global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its THN3 Clinical Study.

10 Nov 2014

Study: Tonsil removal for children with sleep apnea decreases asthma severity

Surgical removal of the tonsils and adenoids in children suffering from sleep apnea is associated with decreased asthma severity, according to the first large study of the connection, published in the journal PLOS Medicine.

4 Nov 2014

Insomnia contributes to deaths caused by motor vehicle crashes, other fatal injuries

New research suggests that insomnia is a major contributor to deaths caused by motor vehicle crashes and other unintentional fatal injuries. The results underscore the importance of the "Sleep Well, Be Well" campaign of the National Healthy Sleep Awareness Project.

31 Oct 2014

New Clinical Practice Guideline for diagnosis, treatment of acromegaly

The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of acromegaly, a rare condition caused by excess growth hormone in the blood.

31 Oct 2014

Sleep apnea may affect peoples' ability to form new spatial memories

Sleep apnea may affect your ability to form new spatial memories, such as remembering where you parked your car, new research led by NYU Langone Medical Center sleep specialists suggests.

29 Oct 2014

PAP therapy reduces 30-day hospital readmission rates in cardiac patients with sleep apnea

A study of hospitalized cardiac patients is the first to show that effective treatment with positive airway pressure therapy reduces 30-day hospital readmission rates and emergency department visits in patients with both heart disease and sleep apnea.

16 Oct 2014

MGH, MIT partner to accelerate development of diagnostic tools and therapies

A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases. While individual collaborations between MGH and MIT investigators are nothing new, this formalized strategic partnership is designed to accelerate the development of diagnostic tools and therapies.

16 Oct 2014

Consultant Live unveils new online sleep disorders educational program for doctors, nurses

UBM Medica US announces that Consultant Live a leading online community for primary care clinicians, has unveiled a new online sleep disorders educational program to help doctors and nurses help their patients get a good night's rest.

14 Oct 2014

Closer monitoring needed to help prevent repeat strokes

People who have had a stroke or transient ischemic attack (TIA or mini-stroke) are at high risk for a second similar event or other serious medical problems for at least five years and need better follow up and strategies to prevent these problems, according to data presented at the Canadian Stroke Congress.

8 Oct 2014

Tongue fat, size linked to obstructive sleep apnea in obese adults

Obesity is a risk factor for many health problems, but a new Penn Medicine study published this month in the journal Sleep suggests having a larger tongue with increased levels of fat may be a sign of obstructive sleep apnea (OSA) in obese adults.

7 Oct 2014

Easy Breathe offers sleep apnea therapy device, AirSense CPAP

Easy Breathe, the fastest growing online sleep apnea shopping destination, today announced that it now offers the revolutionary AirSense CPAPs by ResMed.

30 Sep 2014

Pharmacy Value Management Solutions and Jeff Liva sign marketing deal

Advanzeon Solutions, Inc., ("Advanzeon" or the "Company"), which provides behavioral health, wellness, pharmacy management services and sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. today announced that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), has entered into a marketing agreement (the "Agreement") with Jeff Liva & Co. ("Dr. Liva"), whereby Dr. Liva, through his Preventive PLUS division will, among other things, introduce the Company's programs to his existing and potential clients and recommend the programs for inclusion in his clients' healthcare benefit packages.

30 Sep 2014

Increasing prevalence of obstructive sleep apnea threatens public health and safety

Public health and safety are threatened by the increasing prevalence of obstructive sleep apnea, which now afflicts at least 25 million adults in the U.S., according to the National Healthy Sleep Awareness Project. Several new studies highlight the destructive nature of obstructive sleep apnea, a chronic disease that increases the risk of high blood pressure, heart disease, Type 2 diabetes, stroke and depression.

29 Sep 2014

Dramatic videos of OSA patients increase CPAP usage

Like more than 20 million other Americans, John Brugger has been diagnosed with sleep apnea. He snored, tossed and turned and struggled to breathe during the night, which often left him not only exhausted the next day but also raised his risk of heart attack, stroke and car accidents.

26 Sep 2014

Screening and treating OSA patients prior to surgery reduce risk of cardiovascular complications

Scheduled for surgery? New research suggests that you may want to get screened and treated for obstructive sleep apnea (OSA) before going under the knife. According to a first-of-its-kind study in the October issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists-, patients with OSA who are diagnosed and treated for the condition prior to surgery are less likely to develop serious cardiovascular complications such as cardiac arrest or shock.

24 Sep 2014

Researchers find that people suffering from sleep apnea have weaker brain blood flow

Employing a measure rarely used in sleep apnea studies, researchers at the UCLA School of Nursing have uncovered evidence of what may be damaging the brain in people with the sleep disorder - weaker brain blood flow.

11 Sep 2014

One year of CPAP therapy restores white matter, improves cognition and mood

A neuroimaging study is the first to show that white matter damage caused by severe obstructive sleep apnea can be reversed by continuous positive airway pressure therapy.

9 Sep 2014

Endo International introduces topical testosterone gel, FORTESTA Gel

Endo International plc announced today that it has introduced the first and only generic 2% topical testosterone gel, an authorized generic of FORTESTA® Gel (testosterone gel) CIII.

8 Sep 2014

Sleeping 7 to 8 hours per night associated with lowest risk of work absence

New research suggests that sleeping 7 to 8 hours per night is associated with the lowest risk of absence from work due to sickness.

4 Sep 2014

Study sheds new light on sleep drunkenness disorder

A study is shining new light on a sleep disorder called "sleep drunkenness". The disorder may be as prevalent as affecting one in every seven people. The research is published in the August 26, 2014, print issue of Neurology, the medical journal of the American Academy of Neurology.

26 Aug 2014